Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:22 pm Sale |
2025-03-03 | 13D | Indivior PLC INDV |
Two Seas Capital LP | 11,579,819 9.300% |
-427,695 (-3.56%) |
Filing History |
| 2025-02-14 09:32 am Purchase |
2024-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 2,947,747 9.990% |
1,131,363 (+62.29%) |
Filing History |
| 2025-02-14 09:31 am Purchase |
2024-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Two Seas Capital LP | 89,010,876 5.800% |
89,010,876 (New Position) |
Filing History |
| 2025-01-17 4:20 pm Sale |
2025-01-15 | 13D | Indivior PLC INDV |
Two Seas Capital LP | 12,007,514 9.600% |
-1,022,513 (-7.85%) |
Filing History |
| 2024-11-14 08:43 am Sale |
2024-09-30 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 1,816,384 8.100% |
-266,254 (-12.78%) |
Filing History |
| 2024-11-14 08:42 am Sale |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
Two Seas Capital LP | 6,584,278 3.300% |
-1,101,842 (-14.34%) |
Filing History |
| 2024-11-14 08:41 am Sale |
2024-09-30 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 8,387,388 4.400% |
-654,539 (-7.24%) |
Filing History |
| 2024-10-17 2:53 pm Sale |
2024-10-15 | 13D | Indivior PLC INDV |
Two Seas Capital LP | 13,030,027 10.100% |
-229,998 (-1.73%) |
Filing History |
| 2024-06-21 6:04 pm Sale |
2024-06-20 | 13D | Indivior PLC INDV |
Two Seas Capital LP | 13,260,025 9.900% |
-295,114 (-2.18%) |
Filing History |
| 2024-03-29 3:59 pm Sale |
2024-03-28 | 13D | Indivior PLC INDV |
Two Seas Capital LP | 13,555,139 9.970% |
-115,173 (-0.84%) |
Filing History |
| 2024-02-14 10:50 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Two Seas Capital LP | 7,686,120 6.800% |
-236,050 (-2.98%) |
Filing History |
| 2024-02-14 10:48 am Sale |
2023-12-31 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 9,041,927 5.400% |
-461,176 (-4.85%) |
Filing History |
| 2024-02-14 10:38 am Purchase |
2023-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 2,082,638 9.990% |
69,811 (+3.47%) |
Filing History |
| 2023-11-21 08:00 am Purchase |
2023-11-21 | 13G | Arbutus Biopharma Corporation ABUS |
Two Seas Capital LP | 9,503,103 5.700% |
9,503,103 (New Position) |
Filing History |
| 2023-10-05 09:00 am Purchase |
2023-10-05 | 13G | Esperion Therapeutics, Inc. ESPR |
Two Seas Capital LP | 7,922,170 7.400% |
7,922,170 (New Position) |
Filing History |
| 2023-10-02 4:34 pm Purchase |
2023-09-22 | 13D | Indivior PLC INDV |
Two Seas Capital LP | 13,670,312 9.900% |
13,670,312 (New Position) |
Filing History |
| 2023-02-13 4:07 pm Purchase |
2022-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 2,012,827 9.990% |
810,205 (+67.37%) |
Filing History |
| 2022-02-11 4:07 pm Purchase |
2021-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 1,202,622 8.200% |
33,459 (+2.86%) |
Filing History |
| 2021-02-10 12:42 pm Purchase |
2020-12-31 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 1,169,163 9.300% |
379,419 (+48.04%) |
Filing History |
| 2020-09-01 08:07 am Purchase |
2020-08-25 | 13G | Odyssey Marine Exploration, Inc. OMEX |
Two Seas Capital LP | 789,744 6.500% |
789,744 (New Position) |
Filing History |